{"identifier":"nobleid:/w1/20260521/8DBDFDA9","arkIdentifier":"ark:/48914/w1/20260521/8DBDFDA9","version":1,"workTitle":"Rituximab, Bendamustine and Cytarabine Followed By Venetoclax (V-RBAC) in High-Risk Older Patients with Mantle Cell Lymphoma: A Phase 2 Study By the Fondazione Italiana Linfomi (FIL)","workType":"Journal Article","authors":"Carlo Visco, Valentina Tabanelli, Maria Vittoria Sacchi, Andrea Evangelista, Isacco Ferrarini, Maria Chiara Tisi, A Merli, Stefano Fiori, Vittorio Ruggero Zilioli, Alessandro Re","description":null,"workUrl":null,"existingDoi":"10.1182/blood-2023-179169","createdAt":"2026-05-21T12:12:04.075411Z","canonicalUrl":"https://nobleid.org/ark:/48914/w1/20260521/8DBDFDA9.v1"}